Skip to Content

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial VICCTHO0398


Molecular Predictors of Lung Cancer Behavior. (SPORE)

Principal Investigator(s)

Pierre Massion


  • Protocol No. VICCTHO0398
  • Open Date: 12/04/2003
  • Staging: N/A
  • Age Group: Adults
  • Scope: Local
  • Objective:
  • Disease Sites: Lung; Non Small Cell; Small Cell
  • Therapies: Correlative
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University; Veterans Administration
  • National Clinical Trial ID: NCT00898313
  • Secondary Protocol No: VICCTHO0398


None Provided.


Ages Eligible for Study:18 Years and older
Genders Eligible for Study:All
Accepts Healthy Volunteers:No


Inclusion Criteria:
-All adults referred to Vanderbilt Medical Center, Veterans Administration Medical Center, St. Thomas Hospital and Meharry Medical Center for evaluation of signs or symptoms of lung cancer.
Exclusion Criteria:
• Inability to provide informed consent
• Minors
• Pregnant women